Halcyon Labs Profile
Key Indicators
- Authorised Capital ₹ 1.80 Cr
- Paid Up Capital ₹ 6.57 M
- Company Age 40 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 156,034.81 Cr
- Satisfied Charges ₹ 24.50 Cr
- Revenue Growth 5.11%
- Profit Growth -12.83%
- Ebitda -36.96%
- Net Worth 7.06%
- Total Assets 8.31%
About Halcyon Labs
Halcyon Labs Private Limited (HLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 May 1984 and has a history of 40 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Veritas Chemicals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.80 Cr and a paid-up capital of Rs 6.57 M.
The company currently has active open charges totaling ₹156,034.81 Cr. The company has closed loans amounting to ₹24.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rupa Merchant, Aditya Merchant, Nandini Merchant, and One other member serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH1984PTC033021
- Company No.
033021
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 May 1984
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Halcyon Labs Private Limited offer?
Halcyon Labs Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Respiratory System Drugs, Anti Asthma Drug, Common Disease Medicines, Skin Ointment, Nervous System and Antipsychotic API, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Halcyon Labs?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Aditya Merchant ![]() | Managing Director | 01-Aug-2009 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rupa Merchant ![]() | Director | 11-Sep-1989 | Current |
Nandini Merchant ![]() | Director | 19-Jul-2016 | Current |
Amrita Merchant ![]() | Director | 10-Jan-2020 | Current |
Financial Performance of Halcyon Labs.
Halcyon Labs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.11% increase. The company also saw a substantial fall in profitability, with a 12.83% decrease in profit. The company's net worth moved up by a moderate rise of 7.06%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Halcyon Labs?
In 2023, Halcyon Labs had a promoter holding of 9.22% and a public holding of 90.78%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹156,034.81 Cr
₹24.50 Cr
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 156025.31 Cr
- Others : 9.50 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
17 Oct 2024 | Others | ₹2.00 Cr | Open |
30 Mar 2024 | Others | ₹7.50 Cr | Open |
10 Oct 2001 | Bank Of Baroda | ₹5.00 M | Open |
11 Oct 2000 | Bank Of Baroda | ₹8.30 Cr | Open |
13 Jul 1998 | Bank Of Baroda | ₹2.50 Cr | Open |
How Many Employees Work at Halcyon Labs?
Halcyon Labs has a workforce of 77 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Halcyon Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Halcyon Labs's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.